Literature DB >> 31619867

Diagnostic precision of sentinel lymph node biopsy in penile cancer.

Jose Gustavo Ramos1, David Camilo Jaramillo1, David Sandoval1, Laura Juliana Gallego1, Carlos Riveros1, Jonathan Armando Sierra1, Isis Vargas1, Byron Eduardo López De Mesa López1, Linda Ibata1, Rodolfo Varela1.   

Abstract

INTRODUCTION: Sentinel lymph node biopsy (SLNB) was designed as a minimally invasive method for evaluation of nodal involvement in patients with penile cancer and nonpalpable lymph nodes. Nevertheless, SLNB is not used in a regular basis due to the lack of studies that adequately characterize the performance of this procedure. The purpose of this study was to evaluate the diagnostic performance of SLNB in patients with infiltrative penile carcinoma without palpable inguinal lymph nodes in a Colombian population.
MATERIALS AND METHODS: This is a retrospective observational study of 89 patients diagnosed with infiltrative penile squamous cell carcinoma with nonpalpable inguinal lymph nodes. These patients underwent partial or complete penectomy, along with SLNB, between 2008 and 2017. Those individuals with a positive SLNB underwent inguinal lymphadenectomy, while those with a negative SLNB were followed on a quarterly basis with a physical examination and imaging to assess relapse. Statistical analysis was done using the STATA 14 software. A contingency table was made to calculate sensitivity, specificity, positive predictive value, negative predictive value, and exactitude, each one with its own confidence interval (CI) of 95%.
RESULTS: There was an average follow-up of 31.4 months, and all 89 patients were evaluated; most primary tumors were T2 (55%), followed by T1 (37%), all of which were subclassified as T1b and T3 (8%). Tumours were most frequently located in the glans (43%). All patients were classified as cN0 and underwent SLNB. Sixty-one patients (69%) tested negative in the SLNB, four of whom (6%) presented with lymph node relapse. On the other hand, 28 patients (31%) tested positive in the SLNB and consequently underwent inguinal lymphadenectomy, seven of whom had negative lymph nodeinvolvement (25% false positives). According to the results, the sensitivity was 84% (95% CI, 65.3-93.6) and the specificity was 89% (95% CI, 79.4-94.7), with a false-negative rate of 6.5%.
CONCLUSIONS: The SLNB using radiotracer can be a useful method for lymph node staging in patients with penile cancer and nonpalpable lymph nodes when performed in experienced centers. Copyright:
© 2019 Indian Journal of Urology.

Entities:  

Year:  2019        PMID: 31619867      PMCID: PMC6792417          DOI: 10.4103/iju.IJU_79_19

Source DB:  PubMed          Journal:  Indian J Urol        ISSN: 0970-1591


  16 in total

1.  Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma.

Authors:  Joost A P Leijte; Bin K Kroon; Renato A Valdés Olmos; Omgo E Nieweg; Simon Horenblas
Journal:  Eur Urol       Date:  2007-02-07       Impact factor: 20.096

2.  Should the dynamic sentinel node biopsy (DSNB) be considered the gold standard in the evaluation of lymph node status in patients with penile carcinoma?

Authors:  Vincenzo Ficarra; Antonio Galfano
Journal:  Eur Urol       Date:  2007-03-16       Impact factor: 20.096

Review 3.  Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer.

Authors:  Ben Hughes; Joost Leijte; Majid Shabbir; Nick Watkin; Simon Horenblas
Journal:  World J Urol       Date:  2008-07-02       Impact factor: 4.226

4.  Management of non-visualization following dynamic sentinel lymph node biopsy for squamous cell carcinoma of the penis.

Authors:  Varun Sahdev; Maarten Albersen; Michelle Christodoulidou; Arie Parnham; Peter Malone; Raj Nigam; Jamshed Bomanji; Asif Muneer
Journal:  BJU Int       Date:  2016-12-21       Impact factor: 5.588

5.  EAU guidelines on penile cancer: 2014 update.

Authors:  Oliver W Hakenberg; Eva M Compérat; Suks Minhas; Andrea Necchi; Chris Protzel; Nick Watkin
Journal:  Eur Urol       Date:  2014-11-01       Impact factor: 20.096

Review 6.  Diagnosis and staging of penile cancer.

Authors:  Chris F Heyns; Arturo Mendoza-Valdés; Antonio C L Pompeo
Journal:  Urology       Date:  2010-08       Impact factor: 2.649

Review 7.  Systematic review of human papillomavirus prevalence in invasive penile cancer.

Authors:  Danielle M Backes; Robert J Kurman; Jeanne M Pimenta; Jennifer S Smith
Journal:  Cancer Causes Control       Date:  2008-12-11       Impact factor: 2.506

8.  Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience.

Authors:  Antonio Augusto Ornellas; Eduardo Wei Kinchin; Bernardo Lindenberg Braga Nóbrega; Aristóteles Wisnescky; Nelson Koifman; Raul Quirino
Journal:  J Surg Oncol       Date:  2008-05-01       Impact factor: 3.454

9.  Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology.

Authors:  S Horenblas; H Van Tinteren; J F Delemarre; L M Moonen; V Lustig; R Kröger
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

10.  Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion.

Authors:  W S McDougal
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

View more
  1 in total

Review 1.  Robot-assisted endoscopic inguinal lymphadenectomy: A review of current outcomes.

Authors:  Gilberto José Rodrigues; Giuliano Betoni Guglielmetti; Marcelo Orvieto; Kulthe Ramesh Seetharam Bhat; Vipul R Patel; Rafael Ferreira Coelho
Journal:  Asian J Urol       Date:  2020-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.